2009
DOI: 10.1016/j.vaccine.2009.03.073
|View full text |Cite
|
Sign up to set email alerts
|

Vaccination with human papillomavirus type 16-derived peptides using a tattoo device

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
16
0

Year Published

2010
2010
2021
2021

Publication Types

Select...
6
2
2

Relationship

0
10

Authors

Journals

citations
Cited by 25 publications
(17 citation statements)
references
References 32 publications
1
16
0
Order By: Relevance
“…All classes can induce potent Th1 effects for a variety of antigens [90][91][92][93][94][95][96]. In reality, use of CpGs often generates a balanced and more effective im-mune response.…”
Section: Oligonucleotidesmentioning
confidence: 99%
“…All classes can induce potent Th1 effects for a variety of antigens [90][91][92][93][94][95][96]. In reality, use of CpGs often generates a balanced and more effective im-mune response.…”
Section: Oligonucleotidesmentioning
confidence: 99%
“…Finally, DNA tattooing can cover a large area of skin, which could potentially elicit a stronger immune response. Tattooing devices can also be used to deliver peptide/protein vaccines, and have been proven to induce both humoral and cell-mediated immune responses 10 . We now use skin tattooing routinely in our animal experiments in a DNA prime-protein boost vaccination protocol (three DNA primes followed by two protein boosts over a period of 16 weeks), and we have successfully induced in mice strong immune responses against HIV-1 gp120.…”
Section: Discussionmentioning
confidence: 99%
“…The tattoo delivery of DNA has been found as a cost-effective method that may be used in laboratory conditions when more rapid and more robust immune responses are required (Pokorná et al, 2009). The second method, a novel dry-coated densely packed Macroflux® microprojections array skin patch, was established as an alternate delivery system to intramuscular injection for delivering an alum adjuvanted vaccine Gardasil (Shi et al, 2005).…”
Section: Hpv Vaccines Of the First Generation The Need For Second-gementioning
confidence: 99%